Forget about Vivagel, and the FDA, and Viraleze, and India, and the TGA, and condom coatings. Management are not pushing SPL7013 any more, and with the demise of a treatment for conjunctivitis I think the best thing to do is sell it all off to the highest bidder. Whether the company receives an offer that covers it’s outlay over the years is a mute point, but they can concentrate on DEP, which in itself is not a one trick pony.
So, what do I want?
Phase 2 results and proof of concept!
When do I want it?
Now!
- Forums
- ASX - By Stock
- Ann: Starpharma receives $7.7M R&D tax incentive refund
Forget about Vivagel, and the FDA, and Viraleze, and India, and...
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.5¢ |
Change
0.004(4.40%) |
Mkt cap ! $39.17M |
Open | High | Low | Value | Volume |
9.2¢ | 9.6¢ | 9.2¢ | $81.30K | 864.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 28056 | 9.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.9¢ | 1285 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 28056 | 0.095 |
2 | 110498 | 0.094 |
1 | 26688 | 0.092 |
1 | 49413 | 0.091 |
4 | 122750 | 0.090 |
Price($) | Vol. | No. |
---|---|---|
0.099 | 1285 | 1 |
0.100 | 112106 | 4 |
0.105 | 66531 | 3 |
0.110 | 16500 | 2 |
0.115 | 109827 | 3 |
Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |